In this issue of The Journal, Atkinson and co-workers report analyses of peripheral blood lymphocyte proliferative responses to 38 overlapping synthetic peptides from the 62-kD form of human glutamic acid decarboxylase (GAD). This cytosolic enzyme is a major autoantigen in insulin-dependent diabetes. Autoantibodies to GAD are an established risk factor for diabetes in first degree relatives of affected patients. The authors found that the peripheral blood lymphocytes from patients with early disease, and from their first degree relatives with anti-GAD antibodies, proliferated most frequently after incubation with a 16-residue synthetic peptide that contained the amino acid sequence PEVKEK (proline-glutamic acid-valine-lysine-glutamic acid-lysine) at the carboxyl end (1 
